# K-BASKET, TAS-117, PI3K/AKT Gene Aberration

> **NCT03017521** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 13 (actual)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** TAS-117

## Key facts

- **NCT ID:** NCT03017521
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-21
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017521, "K-BASKET, TAS-117, PI3K/AKT Gene Aberration". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03017521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*